Difference between revisions of "Hancock S"
From Bioblast
Beno Marija (talk | contribs) ย |
|||
(9 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
{{Person}} | {{Person | ||
|lastname=Hancock | |||
|firstname=Saege | |||
|institution=Center for Mitochondrial and Epigenomic Medicine (CMEM) | |||
ย | |||
The Children's Hospital of Philadelphia | |||
|city=Philadelphia | |||
|state=Pennsylvania (PA) | |||
|country=USA | |||
|info=[[IOC61]] | |||
}} | |||
{{Labelingperson | |||
|field of research=Basic | |||
|info=[[IOC61]] | |||
}} | |||
== Participated at== | |||
::::* [[IOC61| IOC61 Schroecken AT]] |
Latest revision as of 17:51, 12 February 2018
Name | Hancock Saege, |
---|---|
Institution | Center for Mitochondrial and Epigenomic Medicine (CMEM)
The Children's Hospital of Philadelphia |
Address | , |
City | Philadelphia |
State/Province | Pennsylvania (PA) |
Country | USA |
Weblink | |
O2k-Network Lab | US PA Philadelphia Wallace DC |
Labels:
Field of research: Basic
Publications
Add references to your publications
Abstracts
Published | Reference | |
---|---|---|
Picard 2014 Abstract MiP2014 | 2014 | Quantitative regulation of nuclear gene expression by mitochondrial DNA heteroplasmy. |